Food and Beverage

Nanosphere Gets FDA Verigene SP, Flu Test Approval

 

NORTHBROOK, Ill. (AP) — Molecular diagnostics maker Nanosphere Inc. said Tuesday the Food and Drug Administration approved its automated Verigene SP system, and a test for the flu and respiratory syncytial virus.

Nanosphere said the FDA granted marketing clearance to both products.

On the Verigene SP system, samples are taken from a patient and processed at the same location, with results available in a few hours, the company said. The new testing product can detect influenza A and B strains, as well as RSV.

RSV produces mild symptoms similar to a cold, but in young and elderly patients, or people with chronic health problems or heart and lung disease, it can cause pneumonia or death.

In premarket trading, Nanosphere shares rose $1.26, or 18 percent, to $8.30.

>To order reprints of this article, click here: Reprints

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet